CBT vs XYL · P/E 16, rev $3.71B vs P/E 27, rev $4.46B
Cabot Corporation (CBT) versus Xylem Inc (XYL) — a side-by-side from cached financials, not a winner call.
Cabot Corporation (CBT) is a specialty chemicals company listed on US.
Xylem Inc (XYL) is a specialty industrial machinery company listed on NYSE.
Latest reported CBT revenue for 2025-09-30 was $3.71B. Net income was $376.0M. CBT currently screens at market cap $4.29B and trailing P/E 15.7.
Latest reported XYL revenue for 2026-06-30 was $4.46B. Net income was $456.0M. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
CBT currently screens at market cap $4.29B and trailing P/E 15.7. XYL currently screens at market cap $26.22B and trailing P/E 27.4.
Not investment advice. Open the CBT and XYL stock pages for the full models.
Not investment advice.